Zeo ScientifiX (ZEOX) Net Cash Flow (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Net Cash Flow of $816000.0 for Q2 2026, up 558.43% year-over-year from $123931.7 in Q2 2025, and up 0.87% quarter-over-quarter from $809000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Net Cash Flow (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Net Cash Flow history runs 15 years deep, the most recent figure standing at $816000.0 for Q2 2026.
- In Q2 2026, Net Cash Flow rose 558.43% year-over-year to $816000.0; the TTM figure through Apr 2026 stood at $1.3 million (up 934.59% YoY), while the FY2025 annual figure was -$436000.0, up 60.33% from the prior year.
- Net Cash Flow for Q2 2026 stood at $816000.0, up from $809000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $3.7 million in Q4 2022, with the low at -$2.3 million in Q1 2023.
- The 5-year median for Net Cash Flow is -$88659.0 (2022), against an average of $100307.1.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow surged 4576.19% in 2022, then tumbled 5848.59% in 2023.
- Zeo ScientifiX's Net Cash Flow stood at $3.7 million in 2022, then tumbled by 69.47% to $1.1 million in 2023, then slumped by 139.89% to -$448000.0 in 2024, then surged by 79.24% to -$93000.0 in 2025, then surged by 977.42% to $816000.0 in 2026.
- Business Quant data shows ZEOX's Net Cash Flow at $816000.0 in Q2 2026, $809000.0 in Q1 2026, and -$93000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 816,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 816,000.00 |
| Apr 30, 2026 | 816,000.00 |
| Jan 31, 2026 | 809,000.00 |
| Jan 31, 2026 | 809,000.00 |
| Oct 31, 2025 | -93,000.00 |
| Oct 31, 2025 | -93,000.00 |
| Jul 31, 2025 | -205,000.00 |
| Jul 31, 2025 | -205,000.00 |
| Apr 30, 2025 | -178,000.00 |
| Apr 30, 2025 | -178,000.00 |
| Jan 31, 2025 | 63,000.00 |
| Jan 31, 2025 | 63,000.00 |
| Oct 31, 2024 | -448,000.00 |
| Oct 31, 2024 | -448,000.00 |
| Jul 31, 2024 | 404,000.00 |
| Jul 31, 2024 | 404,000.00 |
| Apr 30, 2024 | -426,000.00 |
| Apr 30, 2024 | -426,000.00 |
| Jan 31, 2024 | -584,000.00 |
| Jan 31, 2024 | -584,000.00 |